2019 Thomas E. Starzl Transplant Surgery State-of-the-Art Lecture: Clinical Vs Science in Personalizing Immunosuppression

4 (2 votes)

Recorded On: 11/10/2019

Back to Package

  • Registration Closed

Immunosuppression in the liver transplant setting includes multiple drugs aimed at predetermined trough levels, adjusted to time after transplantation. Excellent graft and patient survival supports immunosuppression, but there may be significant short- and long-term risks. At this presentation, experts will discuss clinical approaches to immunosuppression in liver transplant patients, including biomarkers used for safe personalization of this process.

David Mulligan
Abraham Shaked


Clinical Vs Science in Personalizing Immunosuppression
Open to view video.
Open to view video. Presenter: Abraham Shaked
Final Evaluation
Final Evaluation
7 Questions
7 Questions Please complete the following evaluation form to share your feedback on this activity.